Skip to main content

Table 2 Prevalence of anogenital warts

From: Systematic review of the incidence and prevalence of genital warts

Study Country / year Population, setting and age groups Prevalence %
    Males Females Overall
Data based on retrospective administrative databases or medical chart reviews
Marra et al., 2009 [32] Canada (British Columbia) / 2006 Setting: physicians, hospitals and STI clinics (province-wide) 0.16 0.14 0.15
Denominator: general population
Age: all ages
Kliewer et al., 2009 [33] Canada (Manitoba) / 2004 Setting: physician offices and hospitals (province-wide) 0.17 0.13 0.15
Population: general population
Age: all ages
Vittori et al., 2008 [28] Italy / 2005 Setting: random sample of 78 gynecologists stratified by geographic region NA 0.6 NA
Population: female population visiting gynecologists
Age: 14–64 years
Castellsague et al., 2009 [29] Spain / 2005 Setting: representative sample of dermatologists, gynecologists and urologists in the public healthcare setting from 6 autonomous regions 0.20 0.16 0.18
Population: general population (68% of total Spanish population)
Age: 14–64 years
Data based on prospectively collected physician reports
Mariani et al., 2011 [47] Italy / 2010 Setting: 45 extra-hospital gynecologists in gynecological ambulatories stratified by geographic region NA 0.56 NA
Population: female population listed with the above GPs (N = 16,410)
Age: 15–64 years
Pasciullo et al., 2011 [41] Italy / 2009 Setting: geographically representative sample of 650 GPs 0.06 0.03 0.05
Population: population listed with the above GPs (N = 959,778)
Age: ≥15 years
Lee et al., 2010 [46] South Korea / 2008 Setting: gynecological clinics in the top 6 metropolitan cities NA 0.14 NA
Population: female patients visiting the above gynecological clinics (N = 117,381)
Age: all ages
Data based on genital examinations of samples from the general population
Sellors et al., 2000 [48] Canada (Ontario) / 1998-1999 Setting: family practices for cytologic screening randomly selected in proportion to the regional population NA 1.10 NA
Population: female population attending cervical Pap screening with the above family physicians (N = 909)
Age: 15–49 years
Nyári et al., 2004 [49] Hungary (Southeast) / 2000 Setting: outpatient gynecology clinics NA 4.03 NA
Population: randomly selected asymptomatic female population attending the above gynecology clinics (N = 397)
Age: mean 35.5 years (SD 9.7)
Jimenez-Vieyra, 2010 [50] Mexico (Mexico City) / 2002–09 Setting: sexual health clinic NA 3.20 NA
Population: female population attending opportunistic cervical Pap screening at above sexual health clinic (N = 3,232*)
Age: 15–54 years
Vaccarella et al., 2006 [45] Mexico / 2003-2004 Setting: 27 public clinics stratified by geographic region 5.1 NA NA
Population: male population seeking vasectomy in the above clinics (N = 779)
Age: mean 34.0 years
Garcia et al., 2004 [51] Peru / 1997-98 Setting: CBOs (mother’s clubs) from 18 districts NA 2.40 NA
Population: rural female population from the above mother’s clubs (N = 752)
Age: 18–67 years
Nyitray et al., 2008 [44] USA (Tucson and Tampa) / NA Setting: prospective HPV epidemiology study 4.10 NA NA
Population: heterosexual men from general population participating in the above study (N = 222)
Age: 18–40 years
Lan et al., 2008 [52] Vietnam (Bavi district) / 2006 Setting: gynecological examinations performed by physicians NA 0.20 NA
Population: married rural women randomly recruited from the general population (N = 1,012)
   Age: 18–49 years    
  1. AGWs anogenital warts, GP general practitioner, GWs genital warts, N number of individuals examined or followed, NA not available, SD standard deviation, STI sexually transmitted infection.
  2. * Number of Pap tests performed.
  3. Penile condyloma acuminata.